Art. 1 Decision of the EEA Joint Committee No 1/2025 of 9 January 2025 amending Annex II (Techn…

In force

Annex II to the EEA Agreement shall be amended as follows:

1.

The following is inserted after the seventeenth paragraph of the introductory part of Chapter XIII:

‘The EFTA States shall be fully associated with the work of the Member State Coordination Group on Health Technology Assessment, including its subgroups, as established by Article 3 of Regulation (EU) 2021/2282 of the European Parliament and of the Council and shall have the same rights and obligations within it as the EU Member States.

By way of derogation from the previous paragraph, the members designated by the EFTA States shall not be entitled to participate in votes. However, where voting takes place, positions of the members designated by the EFTA States shall be recorded separately upon their request.

Pursuant to Article 12(2) of Regulation (EU) 2021/2282, where consensus cannot be reached, divergent scientific opinions by the EFTA States, including the scientific grounds on which those opinions are based, shall be incorporated in the reports.’

2.

The following is inserted after point 22n (Commission Implementing Regulation (EU) 2024/878) of Chapter XIII:

‘23. 32021 R 2282: Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU (OJ L 458, 22.12.2021, p. 1).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation:

Paragraph 4(a) of Protocol 1 to this Agreement shall not apply to Article 3.’

3.

The following is inserted in the introductory part of Chapter XXX:

‘The EFTA States shall be fully associated with the work of the Member State Coordination Group on Health Technology Assessment, including its subgroups, as established by Article 3 of Regulation (EU) 2021/2282 of the European Parliament and of the Council and shall have the same rights and obligations within it as the EU Member States.

By way of derogation from the previous paragraph, the members designated by the EFTA States shall not be entitled to participate in votes. However, where voting takes place, the positions of the members designated by the EFTA States shall be recorded separately upon their request.

Pursuant to Article 12(2) of Regulation (EU) 2021/2282, where a consensus cannot be reached, divergent scientific opinions by the EFTA States, including the scientific grounds on which those opinions are based, shall be incorporated in the reports.’

4.

The following point is inserted after point 16 (Commission Implementing Regulation (EU) 2022/123) of Chapter XXX:

‘17. 32021 R 2282: Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU (OJ L 458, 22.12.2021, p. 1).

The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation:

Paragraph 4(a) of Protocol 1 to this Agreement shall not apply to Article 3.’